Medical Devices Startups
6,372 companies tagged Medical Devices, with their investors and founders.
Spencer Health Solutions develops a medication management platform featuring a smart home dispenser that tracks adherence and collects real-world health data for patients and healthcare providers. The system integrates connected devices, mobile and web portals, and pre-loaded pharmacy refills to simplify medication compliance.
2 investors
Spineology develops minimally invasive spine surgery implants, including its flagship OptiMesh interbody fusion technology that delivers a bone graft-containing implant through a small surgical portal. The company serves spine surgeons and their patients in the orthopedic medical device market.
2 investors
Spine Wave develops and commercializes expandable and minimally invasive surgical products for spine surgeons and their patients. The company follows a surgeon-driven product-development process to build a portfolio of technology platforms addressing spinal surgical challenges.
2 investors
Spiro Medical is a clinical-stage medical device company developing neuromodulation therapies for severe, uncontrolled asthma and other respiratory conditions. The company targets the neurological mechanisms underlying respiratory disease to provide treatment options for patients who have not benefited from conventional therapies.
2 investors
Spot provides white-label at-home diagnostic testing services for health brands, enabling users to collect and submit lab-analyzed blood, urine, and saliva samples at home. The platform handles sample collection kits, regulatory compliance including doctor orders where required, lab partnerships, and integration of results into customer-facing applications.
2 investors
SpotDoc provides AI-powered full-body skin imaging technology combined with dermatological expertise to detect skin cancer at earlier, more treatable stages. The company uses advanced pattern recognition and imaging analysis to reduce unnecessary biopsies and improve early detection outcomes.
2 investors
Spotlight Pathology develops AI-based diagnostic tools for pathology, particularly focused on blood cancer diagnosis and digital pathology services. The company serves diagnostic laboratories and healthcare centers by providing decision support systems underpinned by machine learning algorithms for image analysis.
2 investors
SpringWorks is a biotechnology company focused on developing innovative treatments for cancer patients. The company combines rigorous scientific research with an operational commitment to rapidly advance therapeutic solutions.
2 investors
Spyre develops and commercializes treatments for a broad range of diseases focused on improving patient outcomes.
2 investors
SquareMind develops Swan, an automated robot for full-body dermoscopy that maps the skin and pairs the scans with AI to support change detection. The system is aimed at making skin exams more efficient and accessible in dermatology.
2 investors
StairMed develops invasive brain-computer interface technology, including ultra-flexible micro-nano electrodes, an implantation-assist device, an implantation surgical robot, and a high-throughput neural signal acquisition system. Its products target neuroscience research and clinical applications addressing conditions such as paralysis, aphasia, blindness, and deafness.
2 investors
STAQ Pharma is an FDA-registered 503B outsourcing facility that compounds and supplies medications to hospitals and healthcare providers across the United States, aiming to address drug shortages. The company is owned and guided by several healthcare systems and focuses on safety, transparency, availability, and quality.
2 investors
Starling Medical develops smart devices and predictive learning solutions focused on preventative bladder health and urinary tract infection management. The company combines digital health technology with clinical analytics to augment standard UTI care.
2 investors
StarTric develops a minimally invasive transcatheter device for repairing the tricuspid heart valve, designed to replicate the open-heart Clover surgical technique for treating tricuspid regurgitation. The device targets cardiology centers and TR patients who cannot undergo open surgery; it is currently under development and not yet available for clinical use.
2 investors
Stimdia Medical develops neuromodulation technologies, with a leadership team focused on clinical and regulatory affairs and R&D in critical care and pulmonary medicine. The company operates in the medical device sector.
2 investors
StimOxyGen develops advanced nanoparticle-based therapies using sonodynamic and oxygen-generating technology for oncology and wound healing. The company focuses on addressing unmet medical needs in cancer treatment and tissue regeneration.
2 investors
Strata Oncology develops precision oncology biomarkers and predictive diagnostic tools for cancer treatment, including treatment response scores for antibody-drug conjugates (ADCs) and an Immunotherapy Response Score for anti-PD-1/PD-L1 therapies. Its algorithms combine measures such as tumor mutation burden and gene expression to help match patients to the most suitable therapy.
2 investors
StrataGen Bio develops technology to convert MRI scans into quantitative biomarker measurements for objective clinical decision-making. The company operates in the medical imaging and diagnostics space.
2 investors
StratifAI develops Polaris, an AI platform that links histology, RNA-seq, and patient outcomes to analyze spatial biology for cancer research. Its first diagnostic, Polaris Breast, assesses metastatic risk in early breast cancer from digitized histology slides and is currently for research use only while pursuing regulatory approval in the EU and US.
2 investors
NeuraNova (formerly StrokeDx) develops non-invasive neurovascular diagnostic technology aimed at rapid detection for stroke and brain-related conditions. Its product is not yet FDA cleared or commercially available.
2 investors
A company offering regenerative and aesthetic medical products for facial, breast, and body treatments across all stages of life. The company develops tissue technologies and platforms to help aesthetic practitioners and patients enhance regenerative treatments.
2 investors
Sunstone Therapies is a clinical research organization with expertise in psychedelic and consciousness research, operating with teams that include researchers from institutions like Johns Hopkins Center for Psychedelic and Consciousness Research and the Dana-Farber Cancer Institute. The company focuses on patient-centered care with clinical rigor in the mental health and oncology spaces.
2 investors
SurgeryAI builds machine-learning scheduling tools for hospital operating theatres, designed to reduce unused capacity and patient wait times. Its software, co-designed with surgeons and operational teams, serves public and private health systems including NHS trusts.
2 investors
Surgical Theater develops an XR visualization platform that helps surgeons plan and execute complex procedures by allowing them to explore patient anatomy in three-dimensional detail. The platform is used by surgical teams and patients to improve surgical outcomes and patient understanding.
2 investors